153 related articles for article (PubMed ID: 23928696)
1. BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway.
Li X; Kong X; Wang Y; Yang Q
Cell Death Dis; 2013 Aug; 4(8):e757. PubMed ID: 23928696
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.
Ma C; Zhan C; Yuan H; Cui Y; Zhang Z
Oncol Rep; 2016 Jun; 35(6):3257-64. PubMed ID: 27035098
[TBL] [Abstract][Full Text] [Related]
4. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
[TBL] [Abstract][Full Text] [Related]
6. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Fan L; Zhang Y; Zhou Q; Liu Y; Gong B; Lü J; Zhu H; Zhu G; Xu Y; Huang G
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30401729
[TBL] [Abstract][Full Text] [Related]
7. BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner.
Broustas CG; Gokhale PC; Rahman A; Dritschilo A; Ahmad I; Kasid U
J Biol Chem; 2004 Jun; 279(25):26780-8. PubMed ID: 15069058
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
[TBL] [Abstract][Full Text] [Related]
9. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway.
Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X
Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444
[TBL] [Abstract][Full Text] [Related]
10. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
12. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
Zhu JH; De Mello RA; Yan QL; Wang JW; Chen Y; Ye QH; Wang ZJ; Tang HJ; Huang T
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165747. PubMed ID: 32109492
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
Imanishi Y; Hu B; Xiao G; Yao X; Cheng SY
J Biol Chem; 2011 Aug; 286(33):29249-29260. PubMed ID: 21680733
[TBL] [Abstract][Full Text] [Related]
14. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
15. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Yang XL; Liu KY; Lin FJ; Shi HM; Ou ZL
Oncol Rep; 2017 Sep; 38(3):1393-1401. PubMed ID: 28713975
[TBL] [Abstract][Full Text] [Related]
16. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
17. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
18. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
Chen J; Wang W; Wang H; Liu X; Guo X
Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
